Antonio Zandona (Author), Gabriela Lihtar (Author), Nikola Maraković (Author), Katarina Miš (Author), Valentina Bušić (Author), Dajana Gašo-Sokač (Author), Sergej Pirkmajer (Author), Maja Katalinić (Author)

Abstract

We evaluated the potential of nine vitamin B3 scaffold-based derivatives as acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors, as a starting point for the development of novel drugs for treating disorders with cholinergic neurotransmission-linked pathology. As the results indicate, all compounds reversibly inhibited both enzymes in the micromolar range pointing to the preference of AChE over BChE for binding the tested derivatives. Molecular docking studies revealed the importance of interactions with AChE active site residues Tyr337 and Tyr124, which dictated most of the observed differences. The most potent inhibitor of both enzymes with Ki of 4 [micro]M for AChE and 8 [micro]M for BChE was the nicotinamide derivative 1-(4'-phenylphenacyl)-3-carbamoylpyridinium bromide. Such a result places it within the range of several currently studied novel cholinesterase inhibitors. Cytotoxicity profiling did not classify this compound as highly toxic, but the induced effects on cells should not be neglected in any future detailed studies and when considering this scaffold for drug development.

Keywords

Alzheimerjeva bolezen;nikotinamid;citotoksičnost;Alzheimer's disease;nicotinamide;cytotoxicity;

Data

Language: English
Year of publishing:
Typology: 1.01 - Original Scientific Article
Organization: UL MF - Faculty of Medicine
UDC: 616-092
COBISS: 34885635 Link will open in a new window
ISSN: 1422-0067
Views: 143
Downloads: 48
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: Slovenian
Secondary keywords: Alzheimerjeva bolezen;nikotinamid;citotoksičnost;
Type (COBISS): Article
Pages: str. 1-19
Volume: ǂVol. ǂ21
Issue: ǂiss. ǂ21
Chronology: 2020
DOI: 10.3390/ijms21218088
ID: 14363900